OTSUKA PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.otsuka.co.jp
Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT06036108
- Locations
- 🇯🇵
Rainbow & Sea Hospital, Saga-shi, Japan
Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.
Recruiting
- Conditions
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2023-03-10
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1600
- Registration Number
- NCT05712746
- Locations
- 🇯🇵
Pharmacovigilance Department, Osaka, Japan
A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT05687071
- Locations
- 🇯🇵
Rinku General Medical Center, Izumisano-shi, Japan
A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT05683340
- Locations
- 🇯🇵
Rinku General Medical Center, Izumisano-shi, Japan
A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 157
- Registration Number
- NCT05615363
- Locations
- 🇯🇵
Harasanshin Hospital, Fukuoka, Japan
A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
- First Posted Date
- 2022-05-13
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT05372653
- Locations
- 🇯🇵
Sotobo Children's Clinic, Isumi, Japan
Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1000
- Registration Number
- NCT05342493
- Locations
- 🇯🇵
Pharmacovigilance Department, Osaka, Japan
A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-13
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 190
- Registration Number
- NCT05326347
- Locations
- 🇯🇵
Hayakawa Clinic, Kure-shi, Japan
Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-13
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 450
- Registration Number
- NCT05325645
- Locations
- 🇯🇵
Hayakawa Clinic, Kure-shi, Japan
A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Registration Number
- NCT05119894
© Copyright 2024. All Rights Reserved by MedPath